AGE-REALTED MACULAR DEGENERATION AND SERUM LEPTIN: A CASE–CONTROL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i3.46658Keywords:
Age-related macular degeneration, Choroidal neovascular membrane, Geographic atrophy, Serum leptin levelAbstract
Objective: The objective of this study was to evaluate the association of serum leptin levels with presence and severity of age-related macular degeneration (AMD).
Methods: A hospital-based case–control study conducted on 84 patients (42 cases and 42 controls) of either sex complaining of diminution of vision aged 40 years and above between August 2019 and 2021.
Results: Mean serum leptin level in cases was 1.55±0.99 ng/mL and control was 2.11±0.88 ng/mL (p<0.008). The serum leptin level was negatively correlated with early (1.06±0.99 ng/mL), intermediate (0.50±0.08 ng/mL), and dry age-related macular degeneration (ARMD) (0.29±0.12 ng/mL). However, we found higher serum leptin levels in exudative ARMD (2.58±0.99 ng/mL). Maximum number of cases were of exudative AMD (42.86%) followed by early AMD (33.34%) and intermediate and dry AMD (11.91% each).
Conclusion: We found a decrease in serum leptin levels as disease severity increases from the early AMD to intermediate AMD and Dry AMD. However, the levels of serum leptin levels were higher in patients with exudative AMD. This may be due to some pathological process that is different in dry and exudative AMD. This can form the basis for further research in future.
Downloads
References
Yanoff M, Jay S. Duker book of ophthalmology. In: 29-Age Related Macular Degeneration. 5th ed., Ch. 6. Netherlands: Elsevier; 2019.
Seshasai S, Liao J, Toh QC, Cheng CY, Cheung GC, Sethi S, et al. Serum leptin and age-related macular degeneration. Invest Ophthalmol Vis Sci 2015;56:1880-6. doi: 10.1167/iovs.14-15933, PMID 25711634
Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, et al. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol 2014;132:272-7. doi: 10.1001/jamaophthalmol.2013.6636, PMID 24385141
Dornbush S, Aeddula NR. Physiology, leptin. In: StatPearls. Treasure Island, FL: StatPearls; 2022.
Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379-88. doi: 10.1111/j.1749-6632.2002.tb04293.x, PMID 12079865
Coppari R, Bjørbæk C. Leptin revisited: Its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 2012;11:692-708. doi: 10.1038/nrd3757, PMID 22935803
Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70. doi: 10.1038/27376, PMID 9796811
Ferńandez-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010;2010:568343. doi: 10.1155/2010/568343, PMID 20368778
Power DA, Noel J, Collins R, O’Neill D. Circulating leptin levels and weight loss in Alzheimer’s disease patients. Dement Geriatr Cogn Disord 2001;12:167-70. doi: 10.1159/000051252, PMID 11173891
Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K, et al. Serum leptin level and cognition in the elderly: Findings from the health ABC study. Neurobiol Aging 2009;30:1483-9. doi: 10.1016/j. neurobiolaging.2007.11.024, PMID 18358569
Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009;302:2565-72. doi: 10.1001/ jama.2009.1836, PMID 20009056
Krishnan T, Ravindran RD, Murthy GV, Vashist P, Fitzpatrick KE, Thulasiraj RD, et al. Prevalence of early and late age-related macular degeneration in India: The INDEYE study. Invest Ophthalmol Vis Sci 2010;51:701-7. doi: 10.1167/iovs.09-4114, PMID 19696177
Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-53. doi: 10.1016/s1350-9462(00)00023-9, PMID 11173253
Evereklioglu C, Doganay S, Er H, Cekmen M, Ozerol E, Otlu B. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: A preliminary study. Eye (Lond) 2003;17:350-5. doi: 10.1038/sj.eye.6700345, PMID 12724698
Zhang QY, Tie LJ, Wu SS, Lv PL, Huang HW, Wang WQ, et al. Overweight, obesity, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 2016;57:1276-83. doi: 10.1167/iovs.15- 18637, PMID 26990164.
Isidori AM, Strollo F, Morè M, Caprio M, Aversa A, Moretti C, et al. Leptin and aging: Correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000;85:1954-62. doi: 10.1210/jcem.85.5.6572, PMID 10843181
Saunier V, Merle BM, Delyfer MN, Cougnard-Grégoire A, Rougier MB, Amouyel P, et al. Incidence of and risk factors associated with age-related macular degeneration: Four-year follow-up from the ALIENOR study. JAMA Ophthalmol 2018;136:473-81. doi: 10.1001/ jamaophthalmol.2018.0504, PMID 29596588
Hirvelä H, Luukinen H, Läärä E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996;103:871-7. doi: 10.1016/s0161- 6420(96)30593-9, PMID 8643241
Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s health initiative sight exam ancillary study. Am J Ophthalmol 2007;143:473-83. doi: 10.1016/j. ajo.2006.11.058, PMID 17317391
Published
How to Cite
Issue
Section
Copyright (c) 2022 Dr. Lakshita Maherda, Dr. Kalpana Jain, Dr. Pulak Agarwal, Dr. Poonam Bhargawa
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
